- Home
- UTHR vs SWK Comparison
UTHR vs SWK Comparison
Compare UTHR & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- SWK
- Stock Information
- Founded
- UTHR 1996
- SWK 1843
- Country
- UTHR United States
- SWK United States
- Employees
- UTHR N/A
- SWK N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- SWK Industrial Machinery/Components
- Sector
- UTHR Health Care
- SWK Consumer Discretionary
- Exchange
- UTHR Nasdaq
- SWK Nasdaq
- Market Cap
- UTHR 16.2B
- SWK 13.8B
- IPO Year
- UTHR 1999
- SWK N/A
- Fundamental
- Price
- UTHR $359.23
- SWK $82.00
- Analyst Decision
- UTHR Buy
- SWK Hold
- Analyst Count
- UTHR 14
- SWK 8
- Target Price
- UTHR $370.86
- SWK $100.00
- AVG Volume (30 Days)
- UTHR 313.6K
- SWK 1.8M
- Earning Date
- UTHR 02-19-2025
- SWK 02-05-2025
- Dividend Yield
- UTHR N/A
- SWK 4.00%
- EPS Growth
- UTHR 25.10
- SWK N/A
- EPS
- UTHR 22.72
- SWK N/A
- Revenue
- UTHR $2,756,200,000.00
- SWK $15,381,700,000.00
- Revenue This Year
- UTHR $26.32
- SWK N/A
- Revenue Next Year
- UTHR $10.37
- SWK $1.92
- P/E Ratio
- UTHR $15.82
- SWK N/A
- Revenue Growth
- UTHR 25.04
- SWK N/A
- 52 Week Low
- UTHR $208.62
- SWK $77.70
- 52 Week High
- UTHR $417.82
- SWK $110.88
- Technical
- Relative Strength Index (RSI)
- UTHR 43.90
- SWK 37.29
- Support Level
- UTHR $358.82
- SWK $78.83
- Resistance Level
- UTHR $383.00
- SWK $84.15
- Average True Range (ATR)
- UTHR 9.97
- SWK 2.19
- MACD
- UTHR -0.80
- SWK -0.09
- Stochastic Oscillator
- UTHR 29.51
- SWK 29.79
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.